Abstract:This work focuses on the δ receptor (DOR), a G protein-coupled receptor (GPCR) belonging to the opioid receptor group. DOR is expressed in numerous tissues, particularly within the nervous system. Our study explores computationally the receptor's interactions with various ligands, including opiates and opioid peptides. It elucidates how these interactions influence the δ receptor response, relevant in a wide range of health and pathological processes. Thus, our investigation aims to explore the significance of DOR as an incoming drug target for pain relief and neurodegenerative diseases and as a source for novel opioid non-narcotic analgesic alternatives. We analyze the receptor's structural properties and interactions using Molecular Dynamics (MD) simulations and Gaussian-accelerated MD across different functional states. To thoroughly assess the primary differences in the structural and conformational ensembles across our different simulated systems, we initiated our study with 1 μs of conventional Molecular Dynamics. The strategy was chosen to encompass the full activation cycle of GPCRs, as activation processes typically occur within this microsecond range. Following the cMD, we extended our study with an additional 100 ns of Gaussian accelerated Molecular Dynamics (GaMD) to enhance the sampling of conformational states. This simulation approach allowed us to capture a comprehensive range of dynamic interactions and conformational changes that are crucial for GPCR activation as influenced by different ligands. Our study includes comparing agonist and antagonist complexes to uncover the collective patterns of their functional states, regarding activation, blocking, and inactivation of DOR, starting from experimental data. In addition, we also explored interactions between agonist and antagonist molecules from opiate and opioid classifications to establish robust structure-activity relationships. These interactions have been systematically quantified using a Quantitative Structure-Activity Relationships (QSAR) model. This research significantly contributes to our understanding of this significant pharmacological target, which is emerging as an attractive subject for drug development.

Molecular Proof of Delta Opioid Peptide Receptor on Lymphocytes

Structural Basis for Bifunctional Peptide Recognition at Human Δ-Opioid Receptor

Identification of Human T Cell Receptor Γδ-Recognized Epitopes/Proteins Via CDR3δ Peptide-based Immunobiochemical Strategy

Effect and Mechanism of Opioid Receptor Antagonist on Allograft Rejection

Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells.

Expression of delta opioid receptors and transcripts by splenic T cells.

Distinct Subcellular Distribution of δ-Opioid Receptor Fused with Various Tags in PC12 Cells

Regulation of Delta Opioid Receptor Expression by Anti-Cd3-Epsilon, Pma, and Ionomycin in Murine Splenocytes and T Cells

Distribution of Mrna Encoding a Novel Opioid Receptor in Mouse Brain

Δ-Opioid Suppression of Human Immunodeficiency Virus-1 Expression in T Cells (Jurkat)

The Potential Promoter Regions on the 5 ' Flank Sequence of the Mu Opioid Receptor Gene in Lymphocytes

Molecular Characterization and Functional Expression of Opioid Receptor-Like1 Receptor

Coexpression of Delta- and Mu-Opioid Receptors in Nociceptive Sensory Neurons

IMMUNOELECTRON MICROSCOPIC LOCALIZATION OF Δ OPIOID RECEPTOR IN PRIMARY AFFERENT C FIBER IN THE SPINAL DORSAL HORN IN THE RAT

Design and Synthesis of a Bivalent Ligand to Explore the Putative Heterodimerization of the Mu Opioid Receptor and the Chemokine Receptor CCR5.

Δ-Opioid Receptor Induced Inhibition of Sodium Channel Function

Design and Synthesis of a Bivalent Probe Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Heterodimer

Descriptive molecular pharmacology of the δ opioid receptor (DOR): A computational study with structural approach

Construction and Identification of Lentivector Encoding Rat δ Opioid Receptor shRNA and Human Preproenkephalin Gene

Nerve Growth Factor-Regulated Emergence Of Functional Delta-Opioid Receptors

An engineered trafficking biosensor reveals a role for DNAJC13 in DOR downregulation